¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"indirect reacting bilirubin"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® bilirubin ÇÑ±Û ºô¸®·çºó
¼³¸í   
  ´ãÁóÀÇ ÁÖ¼ººÐÀ¸·Î¼­ Ç÷»ö¼Ò¿¡¼­ À¯·¡ÇÏÁö¸¸ Ã¶À» Æ÷ÇÔÇÏÁö´Â ¾Ê´Â´Ù. »ý¼ºµÇ´Â °÷Àº ÁַΠÁö¶ó, °ñ¼ö µîÀÇ ¸Á³»°è·Î, ºô¸®º£¸£µòÀ» °ÅÃÄ À¯¸®ÇüÀÇ ºô¸®·çºóÀ¸·Î¼­ Ç÷ÁßÀ¸·Î ¹æÃâµÈ´Ù. 85%´Â ³ëÈ­ ÀûÇ÷±¸ÀÇ Ç÷»ö¼Ò¿¡¼­ À¯·¡ÇÑ´Ù. À¯¸®Çü ºô¸®·çºóÀº ¹°¿¡ ³ìÁö ¾Ê´Â´Ù. Ç÷Áß¿¡¼­´Â ¾ËºÎ¹Î°ú °áÇÕÇØ ÀÖÀ¸¸ç ÄáÆÏ¿¡¼­ ¹è¼³µÇÁö ¾ÊÀ¸¸ç, ¶Ç ½Å°æÁ¶Á÷À¸·ÎÀǠģȭ¼ºÀÌ Ä¿ ¾ËºÎ¹Î°ú °áÇÕÇÏÁö ¾ÊÀº °ÍÀº ½Å°æµ¶¼ºÀ» °®´Â´Ù. ¸ðµç Á¶Á÷°ú Ã¼¾×¿¡ ºÐÆ÷Çϸç, °£°ú ÄáÆÏ¿¡¼­ ºô¸®·çºó Ä§ÂøÀÌ ÇöÀúÇÏ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cross-reacting antibody
    ±³Â÷¹ÝÀÀÇ×ü
  • cross-reacting antigen
    ±³Â÷¹ÝÀÀÇ׿ø
  • cross-reacting material
    ±³Â÷¹ÝÀÀ¹°Áú
  • reacting dose
    ¹ÝÀÀ¿ë·®
  • slow-reacting substance
    Áö¿¬¹ÝÀÀ¹°Áú
  • bilirubin
    ºô¸®·çºó
  • bilirubin encephalopathy
    ºô¸®·çºó³úº´(Áõ)
  • bilirubin glucuronide
    ºô¸®·çºó±Û·çÄí·Î´Ïµå
  • conjugate bilirubin
    °áÇÕºô¸®·çºó
  • conjugated bilirubin
    °áÇÕºô¸®·çºó
  • direct bilirubin
    Á÷Á¢ºô¸®·çºó
  • unconjugated bilirubin
    ºñ°áÇÕºô¸®·çºó
  • biologic indirect pulp capping
    »ý¹°ÇÐÀû°£Á¢Ä¡¼öijÇιý
  • indirect
    °£Á¢-
  • indirect adjustment
    °£Á¢º¸Á¤
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bilirubin
    ºô¸®·çºó
  • conjugated bilirubin
    °áÇÕºô¸®·çºó
  • unconjugated bilirubin
    ºñ°áÇÕºô¸®·çºó
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cross-reacting antibody
    ±³Â÷¹ÝÀÀÇ×ü
  • cross-reacting antigen
    ±³Â÷¹ÝÀÀÇ׿ø
  • cross-reacting material
    ±³Â÷¹ÝÀÀ¹°Áú
  • reacting dose
    ¹ÝÀÀ¿ë·®
  • slow-reacting substance
    Áö¿¬¹ÝÀÀ¹°Áú
  • bilirubin
    ºô¸®·çºó
  • bilirubin glucuronide
    ºô¸®·çºó±Û·çÄí·Î´Ïµå
  • bilirubin encephalopathy
    ºô¸®·çºó³úº´Áõ
  • conjugate bilirubin
    °áÇÕºô¸®·çºó
  • direct bilirubin
    Á÷Á¢Çüºô¸®·çºó
  • unconjugate bilirubin
    ºñ°áÇÕºô¸®·çºó
  • indirect adjustment
    °£Á¢º¸Á¤
  • indirect latex agglutination
    °£Á¢¶óÅØ½ºÀÀÁý¹ÝÀÀ
  • biologic indirect pulp capping
    »ý¹°ÇÐÀû°£Á¢Ä¡¼öijÇιý
  • indirect contact
    °£Á¢Á¢ÃË
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • indirect bilirubin
    °£Á¢Çü(ÊàïÈúþ)ºô¸®·çºó.
  • SRS A : slow reacting substance A
    ¿¡½º¾Ë¿¡½º-¿¡ÀÌ.
  • antibody, cross-reacting
    ±³Â÷¹ÝÀÀÇ×ü
  • antigen, cross-reacting
    ±³Â÷¹ÝÀÀÇ׿ø
  • reacting dose
    ¹ÝÀÀ·®(ÚãëëåÖ).
  • agglutination, indirect
    °£Á¢ÀÀÁý¹ý
  • antiglobulin test, indirect
    °£Á¢Çױ۷κҸ° °Ë»ç
  • hemagglutination, indirect
    °£Á¢Ç÷±¸ÀÀÁý¹ý
  • indirect
    °£Á¢
  • indirect Coombs test
    °£Á¢Äñ½º°Ë»ç
  • indirect action
    °£Á¢ÀÛ¿ë.
  • indirect action
    °£Á¢ÀÛ¿ë
  • indirect agglutination
    °£Á¢ÀÀÁý(¹ÝÀÀ).
  • indirect analysis
    °£Á¢ºÐ¼®.
  • indirect antiglobulin test
    °£Á¢Çױ۷κҸ°°Ë»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • indirect bilirubin
    °£Á¢Çü(ÊàïÈúþ)ºô¸®·çºó.
  • bilirubin
    ºô¸®·çºó
  • bilirubin
    ºô¸®·çºó
  • bilirubin glucuronide
    ºô¸®·çºó±Û·çÄí·Î´Ïµå
  • bilirubin metabolism
    ºô¸®·çºó´ë»ç(¡­ÓÛÞó).
  • bilirubin(a)emia
    ºô¸®·çºóÇ÷Áõ(¡­Ç÷Áõ).
  • bilirubin(a)emia
    ºô¸®·çºóÇ÷Áõ(¡­úìñø).
  • delta bilirubin
    µ¨Å¸ºô¸®·çºó
  • antibody, cross-reacting
    ±³Â÷¹ÝÀÀÇ×ü
  • antigen, cross-reacting
    ±³Â÷¹ÝÀÀÇ׿ø
  • coagulase-reacting factor
    Ç÷ÀåÀÀ°íÈ¿¼Ò ¹ÝÀÀÀÎÀÚ, ÄھƱֶóÁ¦ ¹ÝÀÀÀÎÀÚ
  • cross reacting antibody
    ±³Â÷¹ÝÀÀÇ×ü(¡­ù÷ô÷).
  • cross-reacting antibody
    ±³Â÷¹ÝÀÀÇ×ü
  • cross-reacting material
    ±³Â÷¹ÝÀÀ¹°Áú(¡­Úªòõ).
  • minimum reacting dose
    ÃÖ¼Ò¹ÝÀÀ·®(¡­ÚãëëåÖ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • indirect acting bilirubin
    °£Á¢ÀÛ¿ë(ÊàïÈíÂéÄ) ºô¸®·çºó
  • bilirubin
    ºô¸®·çºó
  • bilirubin diglucuronide
    ÀÌ(ì£)±Û·çÅ¥·Ð»ê(ß«) ºô¸®·çºó
  • cross-reacting antibody
    ±³Â÷¹ÝÀÀ Ç×ü(Îßó©Úãëëù÷ô÷)
  • cross-reacting antigen
    ±³Â÷¹ÝÀÀ Ç׿ø(Îßó©Úãëëù÷ê«)
  • cross-reacting material
    ±³Â÷¹ÝÀÀ ¹°Áú(Îßó©ÚãëëÚªòõ)
  • direct-acting bilirubin
    Á÷Á¢¹ÝÀÀ(òÁïÈÚãëë) ºô¸®·çºó
  • slow-reacting substance
    ¿Ï¼Ó(èÐáÜ) ¹ÝÀÀ¹°(ÚãëëÚª)
  • indirect calorimetry
    °£Á¢¿­·®ÃøÁ¤¹ý(ÊàïÈæðÕáö°ïÒÛö)
  • indirect complement fixation test
    °£Á¢º¸Ã¼°íÁ¤½ÃÇè(ÊàïÈÜÍô÷ͳïÒãËúÐ)
  • indirect Coomb's test
    °£Á¢(ÊàïÈ) Äñ½ÃÇè(ãËúÐ)
  • indirect coupling
    °£Á¢(ÊàïÈ) ¦Áþ±â
  • indirect fluoresccnt antibody technique
    °£Á¢ Çü±¤Ç×ü¼ú(ÊàïÈû«ÎÃù÷ô÷âú)
  • indirect induction
    °£Á¢À¯µµ(ÊàïÈë¯Óô)
  • indirect mutagenesis
    °£Á¢º¯ÀÌÀ¯¹ß(ÊàïÈܨì¶ë¯Û¡)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bilirubin
    ºô¸®·çºó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
Hb Hemoglobin; Ç÷»ö¼Ò; 13 - 15 mg%
  1 gm ÆÄ±«½Ã Indirect Bilirubin 40 mg Áõ°¡
  = ...
IFA idiopathic fibrosing alveolitis; immunofluorescence assay; immunofluorescent antibody; incomplete Fr...
IHA idiopathic hyperaldosteronism; indirect hemagglutination; indirect hemagglutination antibody
SRS-A Slow Reacting Substance of Anaphylaxis
BPRS brief psychiatric rating scale; brief psychiatric reacting scale
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
TBARS 2-thiobarbituric acid-reacting substance
CRD Cross Reacting Determinant
CRM Cross-reacting material
NCA Non-specific cross-reacting antigen
SRS-A Slow Reacting Substance of Anaphylaxis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • bilirubin
    ºô¸®·çºó
    1. ´ãÁó ±¸¼º ¼ººÐ Áß Çϳª·Î Ç÷»ö¼Ò ºÐÇØ »ê¹°·ÎºÎÅÍ ¸¸µé¾îÁø´Ù. ¼ö¸íÀÌ ´ÙÇÑ ÀûÇ÷±¸´Â ¼¼¸Á³»Çǰ迡¼­ ÆÄ±«µÇÁö¸¸ Çì¸ð±Û·ÎºóÀÇ ÇðÀº ºô¸®º£¸£µòÀÌ µÈ´Ù. ÇǺÎ, °¢¸· ¹× Á¡¸· µî¿¡ ÃàÀûµÇ¸é Ȳ´ÞÀ» ÀÏÀ¸Å²´Ù. 2. ´ë½Ä ¼¼Æ÷³»¿¡¼­ Ç÷»ö¼Ò°¡ ºÐÇØµÇ¾î »ý¼ºµÇ´Â ´ãÁó »ö¼Ò·Î Ç÷¾×³»¿¡¼­ ¾ËºÎ¹Î°ú °áÇÕÇÏ¿© °£À» °ÅÃÄ °á±¹ ´ãÁóÀ» Çü¼ºÇÏ°Ô µÈ´Ù. ¶ÇÇÑ ÀÌ »ö¼Ò´Â Ç÷ÁßÀ̳ª ÇǺΠ°¢¸· ¹× Á¡¸·¿¡ ÃàÀûÀÌ µÇ±âµµ ÇÑ´Ù. 3. Çì¸ð±Û·Îºó ÆÄ±«¿¡ ÀÇÇÑ ³ëÆó¹°ÀÇ »ö¼Ò.
  • bilirubin test
    ºô¸®·çºó ½ÃÇè
  • conjugated bilirubin
    °áÇÕÇü ºô¸®·çºó
  • coagulase-reacting factor
    Ç÷Àå ÀÀ°í È¿¼Ò ¹ÝÀÀ ÀÎÀÚ
  • cold reacting antibody
    ÇÑ·© Ç×ü
  • minimum reacting dose
    ÃÖ¼Ò ¹ÝÀÀ·®
  • warm-reacting autoimmune hemolytic anemia
    »ó¿Â ¹ÝÀÀ¼º ÀÚ°¡ ¸é¿ª¼º ¿ëÇ÷¼º ºóÇ÷, ¿ÂÇ×ü¿¡ ÀÇÇÑ ¿ëÇ÷
    »ó¿Â ¹ÝÀÀ¼º Ç×ü
  • indirect
    °£Á¢
    Áï½Ã ¶Ç´Â ¹Ù·Î°¡ ¾Æ´Ñ. Áß°£ ¾àÀ縦 ÅëÇØ ÀÛ¿ëÇÏ´Â.
  • indirect agglutination
    °£Á¢ ÀÀÁý¹ý
  • indirect effect
    °£Á¢ È¿°ú
  • indirect hemagglutination
    °£Á¢ Ç÷±¸ ÀÀÁý ¹ÝÀÀ
    ¼öµ¿ÀûÀ¸·Î Ç¥¸é¿¡ ÈíÂø½ÃŰ°Å³ª ¼¼Æ÷¿¡ È­ÇÐÀûÀ¸·Î °áÇÕ½ÃŲ Ç׿ø°ú ƯÀÌÇ×ü »çÀÌÀÇ ¹ÝÀÀ¿¡ ÀÇÇÑ ÀûÇ÷±¸ÀÇ ÀÀÁý.
  • indirect method
    °£Á¢¹ý
    䵿ÇÑ Àλ󿡼­ Á¦ÀÛµÈ ¸ðÇü»ó¿¡¼­ Ä¡°ü ¼öº¹¹°À» Á¦ÀÛÇÏ´Â ¹æ¹ý.
  • indirect pulp capping
    °£Á¢ Ä¡¼ö º¹Á¶¹ý
    »ì±Õ¼º, ÁøÅ뼺, º¸È£¼º ¹°ÁúÀ» Ä¡¼ö°¡ ³ëÃâµÇ±â Á÷ÀüÀÇ ¾ãÀº Ä¡Áú¿¡ µ¤¾î ¾º¿ì´Â °Í.
  • indirect pulp therapy
    °£Á¢ Ä¡¼ö Ä¡·á
  • indirect resin
    °£Á¢ ·¹Áø
    ¿­À» °¡Çؾ߸¸ ÁßÇÕ ¹ÝÀÀÀÌ ÀϾ °íüȭµÇ´Â ¼öÁö.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
indirect reacting bilirubin The fraction of serum bilirubin which has not been conjugated with glucuronic acid in the liver cell; so called because it reacts with the Ehrlich diazo reagent only when alcohol is added; increased levels are found in hepatic disease and haemolytic conditions.
Synonym: unconjugated bilirubin.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
direct reacting bilirubin The fraction of serum bilirubin which has been conjugated with glucuronic acid in the liver cell to form bilirubin diglucuronide; so called because it reacts directly with the Ehrlich diazo reagent; increased levels are found in hepatobiliary diseases, especially of the obstructive variety.
Synonym: conjugated bilirubin.
(05 Mar 2000)
indirect bilirubin <biochemistry> Free bilirubin that has not been attached to a glucuronide molecule. This results from the rapid breakdown of red blood cells. The haemoglobin molecule is normally converted to bilirubin. Greater than normal values of indirect bilirubin can be seen in erythroblastosis foetalis, haemolytic anaemia, sickle cell anaemia, transfusion reactions, pernicious anaemia and resolution of large haematomas.
(27 Sep 1997)
minimal reacting dose The minimal dose of a toxic substance causing a reaction, as manifested in the skin of a series of susceptible test animals; the assay is based on the development of a characteristic, minimal but definite, "standard," focal inflammation (congestion and oedema, induration, degenerative changes, and desquamation of epidermal cells).
(05 Mar 2000)
cross-reacting agglutinin An immune agglutinin specific for a group antigen.
Synonym: cross-reacting agglutinin.
(05 Mar 2000)
cross-reacting antibody <immunology> Antibody specific for group antigens, i.e., those with identical functional groups, antibody for antigens that have functional groups of closely similar, but not identical, chemical structure.
(05 Mar 2000)
cross-reacting material <haematology> A substance sufficiently different from a reference substance (R) to have a perceptibly different function from R but sufficiently similar to R that it reacts with anti-R antibodies; e.g., mutant factor VIII may be defective or even inert in coagulation and yet be immunologically identified as factor VIII.
(05 Mar 2000)
slow-reacting factor of anaphylaxis Slow-reacting substance of anaphylaxis (SRS-A), a leukotriene of low molecular weight which is released in anaphylactic shock and produces slower and more prolonged contraction of muscle than does histamine; it is active in the presence of antihistamines (but not epinephrine) and seems not to occur preformed in mast cells, but as a result of an antigen-antibody reaction on the granules.
Compare: peptidyl leukotrienes.
Synonym: slow-reacting factor of anaphylaxis.
(05 Mar 2000)
slow-reacting substance Slow-reacting substance of anaphylaxis (SRS-A), a leukotriene of low molecular weight which is released in anaphylactic shock and produces slower and more prolonged contraction of muscle than does histamine; it is active in the presence of antihistamines (but not epinephrine) and seems not to occur preformed in mast cells, but as a result of an antigen-antibody reaction on the granules.
Compare: peptidyl leukotrienes.
Synonym: slow-reacting factor of anaphylaxis.
(05 Mar 2000)
slow reacting substance of anaphylaxis <immunology> Potent bronchoconstrictor and inflammatory agent released by mast cells, an important mediator of allergic bronchial asthma.
A mixture of three leukotrienes (LTC4 mainly, LTD4 and LTE4)
(18 Nov 1997)
bilirubin <biochemistry> A pigment produced when the liver processes waste products. A high bilirubin level causes yellowing of the skin.
(16 Dec 1997)
bilirubin encephalopathy <paediatrics> Disorder due to jaundice in a newborn baby with high blood levels of the pigment bilirubin that is deposited in the brain resulting in damage. The level of bilirubin is monitored in newborns to determine whether treatment is needed to prevent kernicterus. With brain affected, it is also called bilirubin encephalopathy.
(12 Dec 1998)
bilirubin glucuronoside glucuronosyltransferase <enzyme> Conjugates one or two glucuronic acid molecules to the carboxyl groups of the propionate side chains of bilirubin thereby removing free bilirubin from the body; ugt1.4 is the minor human bilirubin udp-glucuronosyltransferase (ugt)
Registry number: EC 2.4.1.95
Synonym: bilirubin glucuronyl transferase, bilirubin glucuronyltransferase, bilirubin udp-glucuronosyltransferase, ugt1.4
(26 Jun 1999)
bilirubin monoglucuronide transglucuronidase <enzyme> Is a transferase that transfers a glucuronoside from one molecule of bilirubin glucuronoside to another, forming bilirubin bisglucuronoside and unconjugated bilirubin. A step in haem catabolism.
(05 May 2002)
bilirubin UDP-glucuronyltransferase <enzyme> An enzyme that catalyses the reaction of UDP-glucuronate and bilirubin forming UDP and bilirubin-glucuronoside; a deficiency of this enzyme is associated with Crigler-Najjar syndrome.
(05 Mar 2000)
conjugated bilirubin Conjugated bilirubin = Direct bilirubin. Bilirubin that has been chemically attached to a glucuronide in the liver. The bilirubin that is excreted into the bile by the liver and stored in the gallbladder or transferred to the duodenum. Normal direct bilirubin is 0 to 0.3 mg/dl. Greater than normal values can be seen in bile duct obstruction, cirrhosis, Crigler-Najjar syndrome, Dubin-Johnson syndrome and hepatitis.
(27 Sep 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bilirubin
    ºô¸®·çºó(´ãÁó¼ÓÀÇ ÀûȲ»ö »ö¼Ò)
  • chain-reacting pile
    ¿¬¼â¹ÝÀÀ·Î;¿øÀÚ·Î
  • indirect
    ¶È¹Ù¸£Áö ¾ÊÀº
  • indirect
    (opp.direct);(±æµî)¶È¹Ù¸£Áö ¾ÊÀº;¿ìȸÇÏ´Â;(¸»µî)ºùµÑ·¯´ë´Â;¿¡µÎ¸¥;°£Á¢ÀÇ;°£Á¢ÀûÀÎ;ÀÌÂ÷ÀûÀÎ;¹æ°èÀÇ(secondary);¼ÖÁ÷ÇÏÁö ¾ÊÀº;Á¤Á÷ÇÏÁö ¾ÊÀº;(¹®¹ý)°£Á¢È­¹ýÀÇ
  • indirect aggression
    (´ë¿Ü)¹æ¼ÛÀü;¼±Àü;°£Á¢Ä§·«;ºñ±º»çÀû °ø°Ý
  • indirect cost
    (°æ)°£Á¢ºñ;ÀϹݺñ¿ë
  • indirect discourse
    (¹®¹ý)°£Á¢È­¹ý À½
  • indirect fire
    (±º)°£Á¢ Á¶ÁØ»ç°Ý
  • indirect lighting
    °£Á¢Á¶¸í
  • indirect narration
    INDIRECT DISCOURSE
  • indirect object
    (¹®¹ý)°£Á¢ ¸ñÀû¾î
  • indirect primary
    (¹Ì)°£Á¢ ¿¹ºñ ¼±°Å
  • indirect speech
    (¿µ)INDIRECT DISCOURSE
  • indirect tax
    °£Á¢¼¼
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á